Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-16-138706
Date:2016-08-23
Issuer: GENOMIC HEALTH INC (GHDX)
Original Submission Date:

Reporting Person:

SHAK STEVEN
301 PENOBSCOT DRIVE
REDWOOD CITY, CA 94063

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2016-08-23 M 5,000 a $18.89 332,207 direct
COMMON STOCK 2016-08-23 S 5,000 d $27.24 327,207 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 18.89 2016-08-23 deemed execution date M 5,000 (d) 2016-11-30 common stock 5,000 $18.89 15,000 direct
Footnotes
IDfootnote
f1 these sales of common stock were effected pursuant to rule 10b5-1 sales plan adopted by the reporting person on march 1, 2016.
f2 represents weighted average sale price. actual sale prices ranged from $26.76 to $27.50.
f3 reporting person undertakes to provide upon request by the securities and exchange commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
f4 includes an aggregate of 15,764 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
f5 the option became exercisable as to 25% of the shares on november 30, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.
WhaleWisdom Logo

Elevate your investments